【Abridge完成1.5亿美元C轮融资，估值达8.5亿美元，引领AI医疗记录新篇章】
近日，美国AI医疗临床对话纪录平台Abridge成功完成了1.5亿美元的C轮融资，这标志着公司在AI医疗记录领域的领先地位得到了进一步巩固。本轮融资由知名投资机构Lightspeed和Redpoint Ventures共同领投，包括Mass General Brigham AIDIF、Kaiser Permanente Ventures、Bessemer Venture Partners以及CVS Health Ventures在内的多家现有投资者也积极参与了跟投，使得Abridge的投后估值达到了8.5亿美元。
Abridge致力于利用先进的人工智能技术，将医生与患者的临床对话实时转录为精准的医疗记录，以提升医疗服务的效率和质量。目前，该公司已与超过10000名临床医生签订了软件使用合同，其创新解决方案正在逐步改变医疗行业的信息管理方式。
此轮融资的资金将用于Abridge进一步的研发投入，以优化其AI技术，提升对话转录的准确性和实时性，同时扩大市场覆盖，深化与医疗机构的合作，以满足全球医疗行业对高效、精准医疗记录的需求。
Abridge的首席执行官表示：“我们非常荣幸能得到这些顶级投资机构的认可和支持。这笔资金将使我们能够加速创新，更好地服务于医疗专业人士，帮助他们提供更优质、更个性化的医疗服务。我们的目标是通过AI技术，构建一个更加透明、协作的医疗生态系统。”
Abridge的成功融资和快速增长，凸显了AI在医疗领域的巨大潜力，预示着医疗记录管理将进入一个全新的智能化时代。
英语如下：
**News Title:** “Abridge Raises $150M in Series C Funding, Revolutionizing Medical Records with AI, Valuation Soars to $850M”
**Keywords:** Abridge, AI in healthcare, Series C funding
**News Content:**
**[Abridge Secures $150M in Series C Financing, Valued at $850M, Pioneering AI-Powered Medical Record Transformation]**
Recently, Abridge, the American AI-powered clinical conversation platform, successfully closed a $150 million Series C funding round, further solidifying its position as a leader in AI-driven medical records. The round was co-led by prominent investors Lightspeed and Redpoint Ventures, with participation from existing backers including Mass General Brigham AIDIF, Kaiser Permanente Ventures, Bessemer Venture Partners, and CVS Health Ventures, pushing Abridge’s post-money valuation to $850 million.
Dedicated to leveraging advanced AI technologies, Abridge transcribes physicians’ and patients’ clinical conversations into precise medical records in real-time, enhancing the efficiency and quality of healthcare services. The company has already inked software usage agreements with over 10,000 clinicians, and its innovative solutions are gradually reshaping the healthcare industry’s approach to information management.
The fresh capital will fuel Abridge’s continued R&D efforts to refine its AI capabilities, improving transcription accuracy and speed. Additionally, it will enable the expansion of its market reach and deepen collaborations with healthcare institutions to cater to the global demand for efficient and precise medical documentation.
The CEO of Abridge remarked, “We are thrilled to receive the endorsement and support from these leading investors. This funding will accelerate our innovation, enabling us to better serve healthcare professionals and support them in delivering higher quality, more personalized care. Our goal is to leverage AI to build a more transparent and collaborative healthcare ecosystem.”
Abridge’s substantial funding and rapid growth exemplify the immense potential of AI in healthcare and foreshadow the advent of a new era of intelligent medical record management.
【来源】https://www.forbes.com/sites/katiejennings/2024/02/23/abridge-raises-150-million-to-make-ai-medical-scribes-even-smarter/
Views: 3